← back to search

Alexander Marson

UCSF Helen Diller Family Comprehensive Cancer Center · US
Area of research
Immunology · Molecular Biology
Research interest
Research interests include Immune Cell Function and Interaction, CRISPR and Genetic Engineering, CAR-T cell therapy research, and T-cell and B-cell Immunology.
h-index
59
citations
19,928
works
221
NIH funding
primary concept
Biology
email

Recent publications

Integrated epigenetic and genetic programming of primary human T cells
Nature Biotechnology 2025cited by 16position: middledoi
Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy
Neuro-Oncology 2025cited by 12position: middledoi
Site-specific DNA insertion into the human genome with engineered recombinases
Nature Biotechnology 2025cited by 8position: middledoi
Causal modelling of gene effects from regulators to programs to traits
Nature 2025cited by 6position: middledoi
FOXP3 expression depends on cell-type-specific cis-regulatory elements and transcription factor circuitry
Immunity 2025cited by 5position: lastdoi
Improving prime editing with an endogenous small RNA-binding protein
Nature 2024cited by 206position: middledoi
Bidirectional epigenetic editing reveals hierarchies in gene regulation
Nature Biotechnology 2024cited by 40position: middledoi
Method of moments framework for differential expression analysis of single-cell RNA sequencing data
Cell 2024cited by 32position: middledoi
Central control of dynamic gene circuits governs T cell rest and activation
Nature 2024cited by 25position: lastdoi
Gene regulatory network inference from CRISPR perturbations in primary CD4+ T cells elucidates the genomic basis of immune disease
Cell Genomics 2024cited by 13position: middledoi
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
Nature Biomedical Engineering 2023cited by 128position: middledoi
CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
Nature 2023cited by 90position: lastdoi
Base-editing mutagenesis maps alleles to tune human T cell functions
Nature 2023cited by 89position: lastdoi
Modular pooled discovery of synthetic knockin sequences to program durable cell therapies
Cell 2023cited by 62position: lastdoi
A single-amino acid substitution in the adaptor LAT accelerates TCR proofreading kinetics and alters T-cell selection, maintenance and function
Nature Immunology 2023cited by 34position: middledoi
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
Cancer Cell 2022cited by 341position: middledoi
CRISPR activation and interference screens decode stimulation responses in primary human T cells
Science 2022cited by 309position: lastdoi
Obesity alters pathology and treatment response in inflammatory disease
Nature 2022cited by 242position: lastdoi
RASA2 ablation in T cells boosts antigen sensitivity and long-term function
Nature 2022cited by 217position: lastdoi
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
Nature Biotechnology 2022cited by 216position: lastdoi
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies
Science Translational Medicine 2022cited by 89position: middledoi
Systematic discovery and perturbation of regulatory genes in human T cells reveals the architecture of immune networks
Nature Genetics 2022cited by 88position: lastdoi
CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells
Science 2022cited by 84position: middledoi
CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells
Nucleic Acids Research 2022cited by 77position: middledoi
A functional map of HIV-host interactions in primary human T cells
Nature Communications 2022cited by 52position: middledoi
Modular Pooled Discovery of Synthetic Knockin Sequences to Program Durable Cell Therapies
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 8position: lastdoi
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Cell 2021cited by 394position: middledoi
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
Cell Reports 2021cited by 200position: middledoi
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
Frontiers in Immunology 2021cited by 128position: middledoi
XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment
Science Advances 2021cited by 116position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Theodore L. Roth · University of San Francisco21 papers (2018–2025)Eric Shifrut · Medical University of Graz14 papers (2018–2024)Chun Ye · University of California, San Francisco12 papers (2015–2024)Jeffrey A. Bluestone · Fort Ross Conservancy10 papers (2015–2022)Zhongmei Li · East China University of Science and Technology9 papers (2019–2025)Nevan J. Krogan · QB39 papers (2016–2024)Kathrin Schumann · University of Konstanz9 papers (2015–2020)Brian R. Shy · Gladstone Institutes9 papers (2021–2025)Judd F. Hultquist · Northwestern University8 papers (2016–2022)Dimitre R. Simeonov · University of California, San Francisco8 papers (2015–2020)David N. Nguyen · Multimeric Biotherapeutics (United States)8 papers (2019–2023)Franziska Blaeschke · German Cancer Research Center8 papers (2019–2022)Joseph Hiatt · Gladstone Institutes7 papers (2018–2022)Justin Eyquem · Gladstone Institutes7 papers (2021–2025)Jonathan K. Pritchard · Stanford Medicine7 papers (2019–2025)Rachel E. Gate · University of California, San Francisco6 papers (2015–2024)Jonathan M. Woo · University of California, San Francisco6 papers (2016–2022)Jennifer A. Doudna · QB36 papers (2015–2022)Michelle Nguyen · Arcturus Therapeutics (United States)5 papers (2017–2020)Ralf Schmidt · Heidelberg University5 papers (2022–2025)